請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/54976
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 周涵怡 | |
dc.contributor.author | Tzu-Wei Shen | en |
dc.contributor.author | 沈之為 | zh_TW |
dc.date.accessioned | 2021-06-16T03:43:13Z | - |
dc.date.available | 2020-03-12 | |
dc.date.copyright | 2015-03-12 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2015-02-10 | |
dc.identifier.citation | 1. Cohen P: The origins of protein phosphorylation. Nature cell biology 2002, 4(5):E127-130.
2. Kastan MB, Bartek J: Cell-cycle checkpoints and cancer. Nature 2004, 432(7015):316-323. 3. Solaini G, Sgarbi G, Baracca A: Oxidative phosphorylation in cancer cells. Biochimica et biophysica acta 2011, 1807(6):534-542. 4. Blume-Jensen P, Hunter T: Oncogenic kinase signalling. Nature 2001, 411(6835):355-365. 5. Eichhorn PJ, Creyghton MP, Bernards R: Protein phosphatase 2A regulatory subunits and cancer. Biochimica et biophysica acta 2009, 1795(1):1-15. 6. Wera S, Hemmings BA: Serine/threonine protein phosphatases. The Biochemical journal 1995, 311 ( Pt 1):17-29. 7. Cohen PT: Novel protein serine/threonine phosphatases: variety is the spice of life. Trends in biochemical sciences 1997, 22(7):245-251. 8. Brewis ND, Street AJ, Prescott AR, Cohen PT: PPX, a novel protein serine/threonine phosphatase localized to centrosomes. The EMBO journal 1993, 12(3):987-996. 9. Toyo-oka K, Mori D, Yano Y, Shiota M, Iwao H, Goto H, Inagaki M, Hiraiwa N, Muramatsu M, Wynshaw-Boris A et al: Protein phosphatase 4 catalytic subunit regulates Cdk1 activity and microtubule organization via NDEL1 dephosphorylation. The Journal of cell biology 2008, 180(6):1133-1147. 10. Mourtada-Maarabouni M, Kirkham L, Jenkins B, Rayner J, Gonda TJ, Starr R, Trayner I, Farzaneh F, Williams GT: Functional expression cloning reveals proapoptotic role for protein phosphatase 4. Cell death and differentiation 2003, 10(9):1016-1024. 11. Mihindukulasuriya KA, Zhou G, Qin J, Tan TH: Protein phosphatase 4 interacts with and down-regulates insulin receptor substrate 4 following tumor necrosis factor-alpha stimulation. The Journal of biological chemistry 2004, 279(45):46588-46594. 12. Shui JW, Hu MC, Tan TH: Conditional knockout mice reveal an essential role of protein phosphatase 4 in thymocyte development and pre-T-cell receptor signaling. Molecular and cellular biology 2007, 27(1):79-91. 13. Wang B, Zhao A, Sun L, Zhong X, Zhong J, Wang H, Cai M, Li J, Xu Y, Liao J et al: Protein phosphatase PP4 is overexpressed in human breast and lung tumors. Cell research 2008, 18(9):974-977. 14. Weng S, Wang H, Chen W, Katz MH, Chatterjee D, Lee JE, Pisters PW, Gomez HF, Abbruzzese JL, Fleming JB: Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012, 21(8):1336-1343. 15. Inostroza J, Saenz L, Calaf G, Cabello G, Parra E: Role of the phosphatase PP4 in the activation of JNK-1 in prostate carcinoma cell lines PC-3 and LNCaP resulting in increased AP-1 and EGR-1 activity. Biological research 2005, 38(2-3):163-178. 16. Mourtada-Maarabouni M, Williams GT: Protein phosphatase 4 regulates apoptosis in leukemic and primary human T-cells. Leukemia research 2009, 33(11):1539-1551. 17. Lee DH, Goodarzi AA, Adelmant GO, Pan Y, Jeggo PA, Marto JA, Chowdhury D: Phosphoproteomic analysis reveals that PP4 dephosphorylates KAP-1 impacting the DNA damage response. The EMBO journal 2012, 31(10):2403-2415. 18. Iyengar S, Farnham PJ: KAP1 protein: an enigmatic master regulator of the genome. The Journal of biological chemistry 2011, 286(30):26267-26276. 19. Hu G, Kim J, Xu Q, Leng Y, Orkin SH, Elledge SJ: A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes & development 2009, 23(7):837-848. 20. Frietze S, O'Geen H, Blahnik KR, Jin VX, Farnham PJ: ZNF274 recruits the histone methyltransferase SETDB1 to the 3' ends of ZNF genes. PloS one 2010, 5(12):e15082. 21. Ayyanathan K, Lechner MS, Bell P, Maul GG, Schultz DC, Yamada Y, Tanaka K, Torigoe K, Rauscher FJ, 3rd: Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes & development 2003, 17(15):1855-1869. 22. Schultz DC, Friedman JR, Rauscher FJ, 3rd: Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2alpha subunit of NuRD. Genes & development 2001, 15(4):428-443. 23. Yokoe T, Toiyama Y, Okugawa Y, Tanaka K, Ohi M, Inoue Y, Mohri Y, Miki C, Kusunoki M: KAP1 is associated with peritoneal carcinomatosis in gastric cancer. Annals of surgical oncology 2010, 17(3):821-828. 24. Liu L, Zhao E, Li C, Huang L, Xiao L, Cheng L, Huang X, Song Y, Xu D: TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer. Cancer epidemiology 2013, 37(1):71-78. 25. Fitzgerald S, Sheehan KM, O'Grady A, Kenny D, O'Kennedy R, Kay EW, Kijanka GS: Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients. Journal of gastroenterology and hepatology 2013, 28(6):967-974. 26. Lin LF, Li CF, Wang WJ, Yang WM, Wang DD, Chang WC, Lee WH, Wang JM: Loss of ZBRK1 contributes to the increase of KAP1 and promotes KAP1-mediated metastasis and invasion in cervical cancer. PloS one 2013, 8(8):e73033. 27. Yu C, Zhan L, Jiang J, Pan Y, Zhang H, Li X, Pen F, Wang M, Qin R, Sun C: KAP-1 is overexpressed and correlates with increased metastatic ability and tumorigenicity in pancreatic cancer. Med Oncol 2014, 31(7):25. 28. Gingras AC, Caballero M, Zarske M, Sanchez A, Hazbun TR, Fields S, Sonenberg N, Hafen E, Raught B, Aebersold R: A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. Molecular & cellular proteomics : MCP 2005, 4(11):1725-1740. 29. Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villen J, Li J, Cohn MA, Cantley LC, Gygi SP: Large-scale characterization of HeLa cell nuclear phosphoproteins. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(33):12130-12135. 30. Li X, Lee YK, Jeng JC, Yen Y, Schultz DC, Shih HM, Ann DK: Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression. The Journal of biological chemistry 2007, 282(50):36177-36189. 31. Chang CW, Chou HY, Lin YS, Huang KH, Chang CJ, Hsu TC, Lee SC: Phosphorylation at Ser473 regulates heterochromatin protein 1 binding and corepressor function of TIF1beta/KAP1. BMC molecular biology 2008, 9:61. 32. Vaiopoulos AG, Kostakis ID, Koutsilieris M, Papavassiliou AG: Colorectal cancer stem cells. Stem Cells 2012, 30(3):363-371. 33. Anderson EC, Hessman C, Levin TG, Monroe MM, Wong MH: The role of colorectal cancer stem cells in metastatic disease and therapeutic response. Cancers 2011, 3(1):319-339. 34. Ikebe D, Wang B, Suzuki H, Kato M: Suppression of keratinocyte stratification by a dominant negative JunB mutant without blocking cell proliferation. Genes to cells : devoted to molecular & cellular mechanisms 2007, 12(2):197-207. 35. Theobald B, Bonness K, Musiyenko A, Andrews JF, Urban G, Huang X, Dean NM, Honkanen RE: Suppression of Ser/Thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell death. Molecular cancer research : MCR 2013, 11(8):845-855. 36. Walsh AH, Cheng A, Honkanen RE: Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. FEBS letters 1997, 416(3):230-234. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/54976 | - |
dc.description.abstract | 調控蛋白質轉譯後修飾作用的動態平衡在腫瘤形成與惡化的過程中扮演很重要的角色。近來越來越多文獻報導指出調控磷酸化程度變化的激酶與磷酸酶造成的異常與腫瘤進程有關。蛋白磷酸酶Protein phosphatase 4 (PP4) 是一種絲胺酸/酪胺酸磷酸酶,在乳癌及肺癌末期中有高度表現。然而,高度表現的PP4在腫瘤進程中的功能目前尚不清楚。在DNA修補機制中,PP4會直接去除Transcription Intermediary Factor 1 beta (TIF1β) 在絲胺酸473及絲氨酸824的磷酸化。TIF1β是一個基因表觀遺傳調控者,在許多生理機能上,例如胚胎發育、細胞分化亦或影響腫瘤生成等,都能藉由TIF1β與調控染色質重組的heterochromatin protein 1(HP1)蛋白或其他染色質調控因子的交互作用進一步調控基因的表現。有趣的是,TIF1β的絲胺酸473位點於TIF1β與HP1蛋白結合的序列附近,已知能藉由絲胺酸473的磷酸化與否來調控TIF1β與HP1蛋白的結合能力。在本研究中,我們利用大腸癌為研究模式,探討經由PP4和激酶調控磷酸化TIF1β的動態平衡在大腸癌進程中的分子機制。利用免疫組織染色比較不同病理分期的大腸癌病人組織發現,在高分期大腸癌中PP4的高表現和TIF1β低磷酸化是相符合的,由此可推測在大腸癌進程中PP4會去除TIF1β的磷酸化。磷酸化TIF1β在人類口腔上皮基底層與老鼠腸上皮的crypt region有高度表現,可推測磷酸化TIF1β和上皮細胞的增殖與分化有關。此外,磷酸化TIF1β在老鼠腸腺瘤及致癌HRas誘發的侵入都有高度表現,指出磷酸化TIF1β可能和參與腫瘤進程有關。我們進一步利用探討分化能力不同細胞c-Jun/JunB變異的3D培養模式,發現磷酸化TIF1β只出現在具有分化能力的細胞上。因此我們認為磷酸化TIF1β與具有分化能力的增殖細胞有關進一步影響腫瘤的進程。除此之外,我們證實TIF1β的磷酸化可藉由EGF經RAS-MEK-ERK訊息傳遞路徑刺激,而ERK-1/2可能是TIF1β的激酶之一。根據以上實驗結果發現,PP4和激酶調控TIF1β磷酸化動態平衡可能參與細胞的增殖與分化進而影響大腸癌的進程。 | zh_TW |
dc.description.abstract | Dynamic state of post-translational modifications has been postulated to involve in a wide range of processes in cancer. Notably, dysregulating the balance between kinases and phosphatases leads to change protein phosphorylation status which has amply reported in cancer progression. Protein phosphatase 4 (PP4) is a serine/threonine phosphatase and is highly expressed in terminal stage of breast and lung cancer. However, the function of PP4 in tumor progression remain unclear. PP4 directly acts on serine 473 of Transcription Intermediary Factor 1 beta (TIF1β) phosphorylation during DNA damage response. TIF1β is an intermediary factor of transcription and epigenetic modulator of gene expression in several physiological processes including embryonic development and cell differentiation as well as in establishment and/or progression of some cancers. Interestingly, serine 473 residue of TIF1β affects the binding between TIF1β and heterochromatin protein 1 (HP1) which could regulate chromatin remodeling and epigenetic modulation. In this study, we used human colorectal cancer to investigate the molecular mechanisms regulating phosphorylation/de-phosphorylation of TIF1β through PP4 and its specific kinase in tumor progression. Comparison of immunohistochemistry (IHC) data on different differentiation grades of colon cancer showed low expression of phosphorylated TIF1β which were consistent with high PP4C expression on high grade which provides a link that PP4 may be involved in de-phosphorylation of TIF1β in tumor progression. Our IHC data on basal layer of oral epithelium and crypt region of intestinal epithelium have shown that the phosphorylated TIF1β is an event closely correlated with cellular proliferation and differentiation. In addition, phosphorylated TIF1β was found to be highly expressed in mouse intestine adenoma and oncogenic HRas-induced invasion region indicating that phosphorylated TIF1β is involved in tumor progression. I used 3D culture model with c-Jun/JunB mutants to compare cells in different potentials of differentiation, phosphorylated TIF1β has only been shown in the differentiation proficient cells but not in the differentiation deficient cells. It suggested phosphorylated TIF1β is correlated with cellular differentiation-dependent proliferation to further involve in tumor progression. Furthermore, I confirmed phosphorylated TIF1β could be induced by EGF through RAS-MEK-ERK signaling pathway and ERK-1/2 may be one of the possible kinases. Based on experimental data, I suggest that the phosphorylated TIF1β may be involved in cellular proliferation and differentiation as well as tumor progression through homeostatic balance between PP4 and its kinase. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T03:43:13Z (GMT). No. of bitstreams: 1 ntu-103-R99450012-1.pdf: 3523517 bytes, checksum: b778ab3f2c16239a9f99c5ce28011bc1 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 口試委員會審定書 #
ACKNOWLEDGEMENT 1 中文摘要 2 ABSTRACT 3 CONTENTS 5 LIST OF FIGURES 8 LIST OF SUPPLEMENTARY DATA 9 Chapter 1 Introduction 10 1.1 Post-Translational Modification: Phosphorylation 10 1.2 Protein Phosphatase 4 (PP4) in Cancer 11 1.3 Transcription Intermediary Factor 1 beta (TIF1β) 12 1.4 Phosphorylated TIF1β at Serine 473 13 1.5 Colorectal Cancer (CRC) 14 1.6 Hypothesis and Approach 14 Chapter 2 Specific Aims 16 Chapter 3 Materials and Methods 17 3.1 Antibodies 17 3.2 Colon Tumor Survey Tissue Array 17 3.3 APCmin/+ Mouse Model 17 3.4 Immunohistochemistry Staining 18 3.5 Immunohistochemistry Multiple-staining 18 3.6 Cell Lines and Cell Culture 19 3.7 Cell Treatments 20 3.8 Western Blot Analysis and Antibodies 20 3.9 Transfection and Plasmids 21 3.10 Immunoprecipitation 21 3.11 3-Dimensional Cell Culture System 22 3.12 Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 23 Chapter 4 Results 24 4.1 PP4 expression and phosphorylated TIF1β in human colorectal cancer 24 4.1.1 Overexpression of PP4 in colorectal cancer 24 4.1.2 Phosphorylated TIF1β in colorectal cancer 24 4.2 Roles of phosphorylated TIF1β between normal and tumoral epithelium 26 4.2.1 Phosphorylated TIF1β is correlated with epithelium cellular proliferation and differentiation 26 4.2.2 Phosphorylated TIF1β is involved in tumor progression 26 4.2.3 Phosphorylated TIF1β is associated with cellular proliferation with differentiation potential 27 4.3 Upstream signaling pathway of phosphorylated TIF1β 29 4.3.1 EGF induced TIF1β phosphorylation through RAS-MEK-ERK signaling pathway in human colon cancer cells 29 Chapter 5 Discussion 32 5.1 Phosphorylated TIF1β in cancer 32 5.2 De-phosphorylated TIF1β in cancer 33 5.3 EGF signaling pathway in TIF1β phosphorylation 34 5.4 Inhibitor of PP4C in clinical trial 35 Chapter 6 Conclusion 36 Chapter 7 Future Studies 37 7.1 Functional assays of TIF1β at Ser473 in tumor 37 7.2 Phosphorylated TIF1β in APCmin/+ Mouse Model 38 7.3 Specific kinase of TIF1β at Ser473 in EGF signaling 38 7.4 Interaction Assay of PP4 subunits in EGF signaling 39 REFERENCES 40 FIGURES 45 SUPPLEMENTARY DATA 55 APPENDIX 61 | |
dc.language.iso | en | |
dc.title | TIF1β磷酸化在大腸癌進程中之調控 | zh_TW |
dc.title | Regulation of TIF1β Phosphorylation in Colorectal Cancer Progression | en |
dc.type | Thesis | |
dc.date.schoolyear | 103-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 鄭永銘,李易展,加藤光保 | |
dc.subject.keyword | 大腸癌,磷酸化,PP4,TIF1β,EGF訊息傳遞路徑, | zh_TW |
dc.subject.keyword | Colorectal Cancer,Phosphorylation,PP4,TIF1β,EGF signaling, | en |
dc.relation.page | 69 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2015-02-11 | |
dc.contributor.author-college | 牙醫專業學院 | zh_TW |
dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
顯示於系所單位: | 口腔生物科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 3.44 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。